Skip to main content

Ra Medical Systems, Inc. (RMED)

NYSEAMERICAN: RMED · IEX Real-Time Price · USD
1.74 -0.15 (-7.71%)
Dec 3, 2021 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019201820172016
Revenue
4.417.26.265.875.98
Revenue Growth
-38.81%15.06%6.59%-1.77%-
Cost of Revenue
5.488.854.214.173.14
Gross Profit
-1.08-1.652.051.712.84
Selling, General & Admin
25.9751.5530.4414.955.32
Research & Development
9.014.532.784.521.72
Operating Expenses
34.9856.0833.2119.477.04
Operating Income
-36.06-57.73-31.16-17.76-4.2
Interest Expense / Income
0.110.250.0100
Other Expense / Income
-0.13-1.04-0.3500
Pretax Income
-36.04-56.94-30.82-17.76-4.2
Income Tax
0.010.020.0100
Net Income
-36.05-56.96-30.83-17.77-4.2
Net Income Common
-36.05-56.96-30.83-17.77-4.2
Shares Outstanding (Basic)
21000
Shares Outstanding (Diluted)
21000
Shares Change
223.00%42.47%22.33%8.55%-
EPS (Basic)
-21.22-108.28-83.50-58.75-15.00
EPS (Diluted)
-21.22-108.28-83.50-58.75-15.00
Free Cash Flow Per Share
-16.70-63.58-51.71-20.11-7.54
Gross Margin
-24.45%-22.93%32.78%29.05%47.49%
Operating Margin
-818.59%-801.92%-498.00%-302.56%-70.25%
Profit Margin
-818.27%-791.18%-492.76%-302.64%-70.31%
Free Cash Flow Margin
-644.06%-464.52%-305.10%-103.41%-35.07%
Effective Tax Rate
-0.02%-0.03%-0.03%-0.01%-0.02%
EBITDA
-33.57-54.94-30.18-17.54-4.1
EBITDA Margin
-761.98%-763.19%-482.40%-298.84%-68.66%
EBIT
-35.93-56.69-30.81-17.76-4.2
EBIT Margin
-815.66%-787.50%-492.38%-302.56%-70.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).